KREBS BIOCHEMICALS & INDUSTRIES
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr |
| Equity - Authorised | ₹23 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
| Equity - Issued | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr |
| Equity Paid Up | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | ₹4.17 Cr |
| Total Reserves | ₹-168 Cr | ₹-141 Cr | ₹-121 Cr | ₹-97 Cr | ₹-67 Cr |
| Securities Premium | ₹118 Cr | ₹118 Cr | ₹118 Cr | ₹118 Cr | ₹103 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹-297 Cr | ₹-270 Cr | ₹-250 Cr | ₹-226 Cr | ₹-181 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| Reserve excluding Revaluation Reserve | ₹-168 Cr | ₹-141 Cr | ₹-121 Cr | ₹-97 Cr | ₹-67 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹-146 Cr | ₹-119 Cr | ₹-99 Cr | ₹-75 Cr | ₹-43 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹161 Cr | ₹184 Cr | ₹173 Cr | ₹133 Cr | ₹101 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | ₹0.25 Cr | ₹0.38 Cr | ₹0.56 Cr | ₹1.11 Cr |
| Loans - Others | - | - | - | ₹0.55 Cr | ₹3.55 Cr |
| Other Unsecured Loan | ₹161 Cr | ₹183 Cr | ₹173 Cr | ₹132 Cr | ₹96 Cr |
| Deferred Tax Assets / Liabilities | - | - | - | - | - |
| Deferred Tax Assets | - | - | - | - | - |
| Deferred Tax Liability | - | - | - | - | - |
| Other Long Term Liabilities | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr |
| Long Term Trade Payables | ₹2.44 Cr | ₹4.01 Cr | ₹4.50 Cr | ₹6.27 Cr | ₹5.65 Cr |
| Long Term Provisions | ₹3.06 Cr | ₹3.05 Cr | ₹2.60 Cr | ₹2.63 Cr | ₹2.56 Cr |
| Total Non-Current Liabilities | ₹212 Cr | ₹236 Cr | ₹225 Cr | ₹187 Cr | ₹154 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹18 Cr | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹21 Cr |
| Sundry Creditors | ₹18 Cr | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹21 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹34 Cr | ₹32 Cr | ₹23 Cr | ₹29 Cr | ₹16 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹15 Cr | ₹17 Cr | ₹12 Cr | - | ₹5.51 Cr |
| Interest Accrued But Not Due | ₹14 Cr | ₹9.54 Cr | ₹6.06 Cr | ₹8.18 Cr | ₹3.99 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹4.78 Cr | ₹5.49 Cr | ₹4.70 Cr | ₹21 Cr | ₹6.43 Cr |
| Short Term Borrowings | ₹51 Cr | ₹9.93 Cr | ₹9.99 Cr | ₹9.99 Cr | ₹10.00 Cr |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹51 Cr | ₹9.93 Cr | ₹9.99 Cr | ₹9.99 Cr | ₹10.00 Cr |
| Short Term Provisions | ₹0.79 Cr | ₹1.06 Cr | ₹1.26 Cr | ₹1.17 Cr | ₹1.49 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | - | - | - |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹0.79 Cr | ₹1.06 Cr | ₹1.26 Cr | ₹1.17 Cr | ₹1.49 Cr |
| Total Current Liabilities | ₹104 Cr | ₹62 Cr | ₹49 Cr | ₹78 Cr | ₹48 Cr |
| Total Liabilities | ₹169 Cr | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr |
| ASSETS | |||||
| Gross Block | ₹314 Cr | ₹312 Cr | ₹303 Cr | ₹288 Cr | ₹261 Cr |
| Less: Accumulated Depreciation | ₹168 Cr | ₹163 Cr | ₹156 Cr | ₹149 Cr | ₹143 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹146 Cr | ₹150 Cr | ₹147 Cr | ₹139 Cr | ₹118 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹1.24 Cr | ₹0.16 Cr | ₹2.24 Cr | ₹6.53 Cr | ₹10 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹9.98 Cr | ₹8.77 Cr | ₹7.52 Cr | ₹7.23 Cr | ₹7.71 Cr |
| Other Non Current Assets | - | - | - | - | ₹0.23 Cr |
| Total Non-Current Assets | ₹159 Cr | ₹161 Cr | ₹159 Cr | ₹154 Cr | ₹138 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹6.03 Cr | ₹9.80 Cr | ₹12 Cr | ₹26 Cr | ₹17 Cr |
| Raw Materials | ₹2.31 Cr | ₹2.67 Cr | ₹3.36 Cr | ₹10.00 Cr | ₹8.36 Cr |
| Work-in Progress | ₹3.54 Cr | ₹5.12 Cr | ₹6.39 Cr | ₹12 Cr | ₹6.64 Cr |
| Finished Goods | ₹0.06 Cr | ₹1.51 Cr | ₹1.31 Cr | ₹1.65 Cr | ₹1.39 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹0.08 Cr | ₹0.50 Cr | ₹0.10 Cr | ₹0.61 Cr | ₹0.21 Cr |
| Other Inventory | ₹0.04 Cr | - | ₹0.79 Cr | ₹1.39 Cr | - |
| Sundry Debtors | ₹0.05 Cr | ₹1.90 Cr | ₹0.53 Cr | ₹0.88 Cr | ₹0.30 Cr |
| Debtors more than Six months | - | - | - | - | ₹0.00 Cr |
| Debtors Others | ₹0.05 Cr | ₹1.90 Cr | ₹0.53 Cr | ₹0.88 Cr | ₹0.30 Cr |
| Cash and Bank | ₹0.14 Cr | ₹0.14 Cr | ₹0.09 Cr | ₹0.10 Cr | ₹0.71 Cr |
| Cash in hand | - | ₹0.00 Cr | ₹0.00 Cr | - | ₹0.00 Cr |
| Balances at Bank | ₹0.14 Cr | ₹0.14 Cr | ₹0.08 Cr | ₹0.10 Cr | ₹0.71 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹0.65 Cr | ₹0.54 Cr | ₹0.65 Cr | ₹0.59 Cr | ₹0.47 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹0.17 Cr | ₹0.17 Cr | ₹0.14 Cr | ₹0.10 Cr | ₹0.08 Cr |
| Prepaid Expenses | ₹0.47 Cr | ₹0.38 Cr | ₹0.52 Cr | ₹0.49 Cr | ₹0.40 Cr |
| Other current_assets | - | - | - | - | - |
| Short Term Loans and Advances | ₹3.39 Cr | ₹5.06 Cr | ₹2.85 Cr | ₹8.36 Cr | ₹3.34 Cr |
| Advances recoverable in cash or in kind | ₹0.59 Cr | ₹3.29 Cr | ₹0.56 Cr | ₹0.42 Cr | ₹0.58 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹2.80 Cr | ₹1.77 Cr | ₹2.29 Cr | ₹7.95 Cr | ₹2.76 Cr |
| Total Current Assets | ₹10 Cr | ₹17 Cr | ₹16 Cr | ₹35 Cr | ₹21 Cr |
| Net Current Assets (Including Current Investments) | ₹-93 Cr | ₹-44 Cr | ₹-33 Cr | ₹-43 Cr | ₹-27 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹169 Cr | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr |
| Contingent Liabilities | ₹9.26 Cr | ₹9.26 Cr | ₹5.63 Cr | ₹5.55 Cr | ₹5.49 Cr |
| Total Debt | ₹212 Cr | ₹194 Cr | ₹183 Cr | ₹143 Cr | ₹111 Cr |
| Book Value | - | -55.29 | -46.13 | -34.83 | -23.91 |
| Adjusted Book Value | -67.83 | -55.29 | -46.13 | -34.83 | -23.91 |
Compare Balance Sheet of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹147.3 Cr | -1.2% | -10.2% | -13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -1.2% |
-10.2% |
-13.6% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses